Andreas du Bois

1992–2025 年に発表

149
論文数
32,124
被引用数
90
h 指数
145
i10 指数

被引用数

Andreas du Bois の年別被引用数1993 年: 被引用 3 件1994 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 6 件2001 年: 被引用 8 件2002 年: 被引用 8 件2003 年: 被引用 11 件2004 年: 被引用 16 件2005 年: 被引用 22 件2006 年: 被引用 71 件2007 年: 被引用 75 件2008 年: 被引用 79 件2009 年: 被引用 98 件2010 年: 被引用 157 件2011 年: 被引用 179 件2012 年: 被引用 265 件2013 年: 被引用 224 件2014 年: 被引用 238 件2015 年: 被引用 211 件2016 年: 被引用 257 件2017 年: 被引用 344 件2018 年: 被引用 225 件2019 年: 被引用 1,140 件2020 年: 被引用 1,215 件2021 年: 被引用 1,109 件2022 年: 被引用 864 件2023 年: 被引用 630 件2024 年: 被引用 980 件2025 年: 被引用 384 件2026 年: 被引用 7 件1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,184 件、この内訳の 18.5%中国: 引用元論文 917 件、この内訳の 7.8%イギリス: 引用元論文 915 件、この内訳の 7.8%イタリア: 引用元論文 771 件、この内訳の 6.5%ドイツ: 引用元論文 721 件、この内訳の 6.1%フランス: 引用元論文 576 件、この内訳の 4.9%カナダ: 引用元論文 512 件、この内訳の 4.3%スペイン: 引用元論文 476 件、この内訳の 4%日本: 引用元論文 347 件、この内訳の 3%オーストラリア: 引用元論文 346 件、この内訳の 2.9%ベルギー: 引用元論文 342 件、この内訳の 2.9%オランダ: 引用元論文 332 件、この内訳の 2.8%
0%18.5%その他 28.5%

分野

  • Medicine71.4%
  • Biochemistry, Genetics and Molecular Biology20.2%
  • Immunology and Microbiology2.2%
  • Materials Science0.9%
  • Computer Science0.7%
  • Neuroscience0.6%
  • その他4%

トピック

  • Ovarian cancer diagnosis and treatment13.8%
  • PARP inhibition in cancer therapy8.3%
  • Endometrial and Cervical Cancer Treatments3.8%
  • Intraperitoneal and Appendiceal Malignancies3.3%
  • HER2/EGFR in Cancer Research2.7%
  • Breast Cancer Treatment Studies2.7%
  • その他65.4%

共著者

全論文

検索で開く
  1. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 2,458

  2. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio González-Martı́n, Viola Heinzelmann‐Schwarz, Florence Joly, J.W. Kim, Frédéric Kridelka, Jonathan A. Ledermann, Domenica Lorusso, Sven� Mahner, W. Glenn McCluggage, Iain A. McNeish, Mikio Mikami, Mansoor Raza Mirza, Philippe Morice, Shibani Nicum, Siel Olbrecht, Dearbhaile M. O’Donnell, Patricia Pautier, François Planchamp, Sandro Pignata, Denis Querleu, Isabelle Ray‐Coquard, Alexandros Rodolakis, Jalid Sehouli, Fatih Selçukbırıcık, Cristiana Sessa, Nilanchali Singh, David S.P. Tan, D. Timmerman, Germana Tognon, Jacobus van der Velden, Ignace Vergote, Petronella O. Witteveen, Alain G. Zeimet - Annals of Oncology 2019 被引用: 1,165

  3. A Phase 3 Trial of Bevacizumab in Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 2,152

  4. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

    著者: , , , , , - Cancer 2009 被引用: 1,614

  5. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 600

  6. Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 315

  7. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

    著者: , , , , , , , , , , , , , - The Lancet 2003 被引用: 1,197

  8. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sven� Mahner, Alexander Reuß, Andreas du Bois, Christoph Grimm, Christian Marth, Regina Berger, Nicole Concin, Ting‐Chang Chang, Kazunori Ochiai, Val Gebski, Alison Davis, Philip Beale, Ignace Vergote, Frédéric Kridelka, Hannelore Denys, Vincent Vandecaveye, Francisco José Cândido dos Reis, Maria Del Pilar Estevez-Diz, Gavin Stuart, Helen Mackay, Mark S. Carey, David Cibula, Pavel Dundr, Oliver Dorigo, Jonathan S. Berek, Dearbhaile M. O’Donnell, Feras Abu Saadeh, Ingrid Boere, Christianne Lok, Pluvio Coronado, Nelleke Ottevanger, David S.P. Tan, Joseph Ng, Antonio Gonzalez Martin, Ana Oaknin, Andrés Poveda, Alejandro Perez Fidalgo, Alejandro Rauh-Hain, Karen H. Lu, Carlos López-Zavala, Eva María Gómez-García, Isabelle Ray-Coquard, Xavier Paolettí, Jean‐Emmanuel Kurtz, Florence Joly, Bénédicte Votan, Michael A. Bookman, Kathleen Moore, Rebecca C. Arend, Keiichi Fujiwara, Hiroyuki Fujiwara, Kosei Hasegawa, Ilan Bruchim, Dalia Tsoref, Katsutoshi Oda, Aikou Okamoto, Takayuki Enomoto, Dayana Michel, Hee‐Seung Kim, Jung‐Yun Lee, Asima Mukhopadhyay, Dionyssios Katsaros, Nicoletta Colombo, Sandro Pignata, Domenica Lorusso, Giovanni Scambia, Elise C. Kohn, Jungmin Lee, Iain A. McNeish, Shibani Nicum ほか 16 名 - The Lancet Oncology 2022 被引用: 142

  9. Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

    著者: , , , , , , , , , , , , , , - International Journal of Gynecological Cancer 2011 被引用: 619

  10. ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

    著者: , , , , , , , , , , , , , , , , , , , , - International Journal of Gynecological Cancer 2021 被引用: 140

  11. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

    著者: , , , , , , , , , , , , , , , - International Journal of Gynecological Cancer 2019 被引用: 400

  12. Treatment of recurrent ovarian cancer

    著者: , , , , - Annals of Oncology 2017 被引用: 354

  13. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Emmanuel Kurtz, Sven Ackermann, C. Anthuber, Mustafa Aydoğdu, Angelika Baldauf, Wolfgang Bauer, Dirk Behringer, Antje Belau, Alexandra Bender, Cosima Brucker, Alexander Burges, Ulrich Canzler, Trygve Daabach, Dominik Denschlag, Mustafa Deryal, Steffen Dörfel, Juliane Ebert, Ahmed El-Balat, Tanja Fehm, Susanne Maria Feidicker, Gabriele Feisel-Schwickardi, R. Felberbaum, Matthias Frank, Gerhard Gebauer, Bernd Gerber, Axel Gerhardt, Andrea Gräfe, Martin Grießhammer, Eva‐Maria Grischke, Isolde Gröll, Martina Gropp‐Meier, Dietrich Hager, Volker Hanf, Carla Hannig, Peer Hantschmann, Philipp Harter, Tanja Hauzenberger, Uwe Herwig, Martin Heubner, Carsten Hielscher, Felix Hilpert, T Hitschold, Manfred Hofmann, Christian Jackisch, Wolfgang Janni, Ludwig Kiesel, Yon‐Dschun Ko, H. Koch, Petra Krabisch, Peter Krieger, Thomas Kubin, Thorsten Kühn, Björn Lampe, P. Ledwon, Sabine Lemster, B. Lex, Clemens Liebrich, Ralf Lorenz, Hans‐Joachim Lück, Sven� Mahner, Peter Mallmann, Frederik Marmé, Werner Meier, Wolfgang Meinerz, Götz Menke, Volker Möbus, Thomas Müller, Volker Müller, Tanja Neunhöffer, Angelika Ober ほか 87 名 - The Lancet Oncology 2020 被引用: 162

  14. The systemic treatment of recurrent ovarian cancer revisited

    著者: , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 158

  15. Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

    著者: , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2016 被引用: 296

  16. Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase

    著者: , , , , , , , , , , - Gynecologic Oncology 2016 被引用: 230

  17. Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 被引用: 572

  18. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy

    著者: , , , , , , , , , - Annals of Oncology 2012 被引用: 340

  19. TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)

    著者: , , , , , , , , , , , , , - International Journal of Gynecological Cancer 2019 被引用: 184

  20. ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors

    著者: , , , , , , , , , , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2021 被引用: 104

  21. A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer

    著者: - JNCI Journal of the National Cancer Institute 2003 被引用: 1,130

  22. Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2006 被引用: 751

  23. Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2018 被引用: 183

  24. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ellen L. Goode, Robert A. Vierkant, Melissa C. Larson, Brooke L. Fridley, Claus Høgdall, Joellen M. Schildkraut, Rachel Palmieri Weber, Daniel W. Cramer, Kathryn L. Terry, Elisa V. Bandera, Lisa E. Paddock, Lorna Rodríguez-Rodríguez, Nicolas Wentzensen, Hannah Yang, Louise A. Brinton, Jolanta Lissowska, Estrid Høgdall, Lene Lundvall, Alice S. Whittemore, Valerie McGuire, Weiva Sieh, Joseph H. Rothstein, Rebecca Sutphen, Hoda Anton‐Culver, Argyrios Ziogas, Celeste Leigh Pearce, Anna H. Wu, Penelope M. Webb - British Journal of Cancer 2015 被引用: 157